Close Menu

A University of Michigan team describes distinct androgen receptor effects for compounds depending on their DNA response element interactions in prostate cancer. Using a combination of high-throughput drug screening, fluorescent reporter plasmids, transcriptomics, chromatin immunoprecipitation assays, and other approaches, the researchers screened thousands of compounds, searching for those that curbed cancer growth but spared growth by normal cells.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.